Abstract Metastatic breast cancer may present as a pericardial effusion that can progress to a life‐threatening cardiac tamponade. Pericardial window followed by initial chemotherapy needs to be immediately applied in order to achieve a favorable outcome
ObjectiveIn the cancer population, pericardial effusions are a common and potentially life-threateni...
Ten patients with cardiac tamponade as the first presentation of cardiothoracic malignancy were eval...
Cardiac tamponade complicating malignant pericardial effusion from non-small cell lung cancer (NSCLC...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
With advances in drug treatment of breast cancer, the number of patients experiencing cardiac toxici...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
Malignant pericardial effusion (MPE) is a serious complication of several cancers. The most commonly...
Malignancy accounts for 40%–60% of pericardial effusions. Two individuals with malignant pericardial...
ObjectiveOur aim was to compare systemic chemotherapy (CT) with drainage and with pericardial window...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
ObjectiveIn the cancer population, pericardial effusions are a common and potentially life-threateni...
Ten patients with cardiac tamponade as the first presentation of cardiothoracic malignancy were eval...
Cardiac tamponade complicating malignant pericardial effusion from non-small cell lung cancer (NSCLC...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
With advances in drug treatment of breast cancer, the number of patients experiencing cardiac toxici...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
Malignant pericardial effusion (MPE) is a serious complication of several cancers. The most commonly...
Malignancy accounts for 40%–60% of pericardial effusions. Two individuals with malignant pericardial...
ObjectiveOur aim was to compare systemic chemotherapy (CT) with drainage and with pericardial window...
Despite significant advancements in systemic anticancer therapies, cardiac tamponade remains a serio...
ObjectiveIn the cancer population, pericardial effusions are a common and potentially life-threateni...
Ten patients with cardiac tamponade as the first presentation of cardiothoracic malignancy were eval...
Cardiac tamponade complicating malignant pericardial effusion from non-small cell lung cancer (NSCLC...